...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?
【24h】

Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation?

机译:保留乳房后,与单纯锁骨上放疗相比,腋窝增强疗法是否会增加淋巴水肿?

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To determine independent predictors of lymphedema (LE) after breast radiotherapy and to quantify added risks of LE from regional node irradiation (RNI). MATERIALS AND METHODS: A total of 2,579 women with T1-2, N 0-3, M0 breast cancer treated with breast conservation between 1970 and 2005 were studied. A total of 2,169 patients (84%) received radiation to the breast (B), 226 (8.8%) to the breast and supraclavicular LNs (B+SC), and 184 (7.1%) to the breast, supraclavicular LNs, and a posterior axillary boost (B+SC+PAB). Median follow-up was 81 months (range, 3-271). RESULTS: Eighteen percent of patients developed LE. LE risks were as follows: 16% (B), 23% (B+SC), and 31% (B+SC+PAB) (p < 0.0001). LE severity was greater in patients who had RNI (p = 0.0002). On multivariate analysis, RT field (p < 0.0001), obesity index (p = 0.0157), systemic therapy (p = 0.0013), and number of LNs dissected (p < 0.0001) independently predicted for LE. In N1 patients, the addition of a SC to tangents (p < 0.0001) and the addition of a PAB to tangents (p = 0.0017) conferred greater risks of LE, but adding a PAB to B+SC RT did not (p = 0.8002). In the N2 patients, adding a PAB increased the risk of LE 4.5-fold over B+SC RT (p = 0.0011). CONCLUSIONS: LE predictors included number of LNs dissected, RNI, obesity index, and systemic therapy. LE risk increased when a SC or PAB were added in the N1 subgroup. In the N2 patients, a PAB increased the risk over B+SC. The decision to boost the axilla must be weighed against the increased risk of LE that it imposes.
机译:目的:确定乳腺癌放疗后淋巴水肿(LE)的独立预测因子,并量化区域淋巴结照射(RNI)导致LE的附加风险。材料与方法:研究了1970年至2005年间共2579例经保乳治疗的T1-2,N 0-3,M0乳腺癌妇女。共有2169例患者(84%)接受了对乳房(B)的放射,226例(8.8%)的对乳房和锁骨上LN(B + SC)的放射,以及184例(7.1%)的乳腺,锁骨上的LN和放射后腋增强(B + SC + PAB)。中位随访时间为81个月(范围3-271)。结果:18%的患者发展为LE。 LE风险如下:16%(B),23%(B + SC)和31%(B + SC + PAB)(p <0.0001)。患有RNI的患者的LE严重程度更高(p = 0.0002)。在多变量分析中,独立预测了LE的RT视野(p <0.0001),肥胖指数(p = 0.0157),全身治疗(p = 0.0013)和解剖的LN数量(p <0.0001)。在N1例患者中,在切线中添加SC(p <0.0001),在切线中添加PAB(p = 0.0017)会增加发生LE的风险,但在B + SC RT中添加PAB却没有(P = 0.8002) )。在N2病人中,添加PAB可使LE的风险比B + SC RT高4.5倍(p = 0.0011)。结论:LE预测因素包括解剖的LN数量,RNI,肥胖指数和全身治疗。在N1亚组中添加SC或PAB会增加LE风险。在N2患者中,PAB的风险高于B + SC。增强腋窝的决定必须权衡其施加的LE风险的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号